– the leading provider of online annual reports to individual and institutional investors.

BioMimetic Therapeutics

BioMimetic Therapeutics, Inc. is an emerging leader in the development and commercialization of drug-device combination products for the repair of orthopedic injuries to bones, cartilage, ligaments, and tendons. BioMimetic's suite of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds, actively stimulating tissue healing and regeneration.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports